Epistem expected to sign more partners as TB test gets European approval, says broker

Stem cell specialist Epistem is likely to sign more partners for its Genedrive diagnostic platform, after being granted a CE mark as an in-vitro diagnostic medical device, reckons broker Peel Hunt.